UNSPSC 51101661: Glycobiarsol
Commodity
Code facts
- Part of
-
-
51000000
-
51100000
- 51101600
-
51100000
-
51000000
- NIGP codes
- 1
UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.
NIGP codes for 51101661
| NIGP code |
|---|
| 26908 Anti-Infective Agents |
Definition
This classification denotes an antiprotozoal agent with the molecular formula C8H9AsNO5.Bi.O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier E3U8347QWJ, chemically known as bismuth, (hydrogen n-glycoloylarsanilato)oxo- (8ci) but generally known as glycobiarsol, which bears US NIH Compound Identifier 16682839. European Medicines Agency schedules Glycobiarsol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07950MIG.
Read the full definition
The term GLYCOBIARSOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 37, No. 6, 1983, List 23). World Health Organization schedules glycobiarsol in its Anatomical Therapeutic Chemical (ATC) Classification. GLYCOBIARSOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. As of Q4 2014, GLYCOBIARSOL remains the US FDA Preferred Term for this commodity. Glycobiarsol bears US NLM identifiers UMLS ID C0301343 and NCI Concept Code C76421. SMILES: [BI](=O)O[AS](=O)(O)C1CCC(NC(=O)CO)CC1.
About UNSPSC 51101661
UNSPSC 51101661 Glycobiarsol is a Commodity code that classifies pharmaceutical active ingredients and medicinal compounds for state and local health and emergency services procurement. Recent state and local opportunities show the code applied to pharmaceutical supply contracts sourced through cooperative purchasing vehicles and direct competitive bidding, though neither recent opportunity involves glycobiarsol itself — the Illinois Department of Public Health contract delivered antibiotics (Doxycycline Hyclate and Ciprofloxacin Hydrochloride) and the Seminole County, Florida solicitation sought Naloxone and drug deactivation systems. State and local health departments and county public health authorities drive the demand under this code, pursuing pharmaceutical inventory through piggyback contracts on established cooperative purchasing consortia (such as MMCAP Infuse) and through standalone competitive bids. Vendors must meet standard compliance requirements, including E-Verify authorization, drug-free workplace certification, and appropriate insurance coverage when applicable.
Activity under the code spans at least Florida and Illinois, with the Illinois Department of Public Health executing a $2,999,999.11 multi-year piggyback award to Chartwell Rx LLC through MMCAP Infuse on August 28, 2026 for pharmaceutical warehouse supply. Seminole County, Florida posted an Invitation for Bid (IFB 60459723LAS) in June 2026 for annual Naloxone and drug deactivation system procurement with quarterly deliveries and an initial two-year term. Both opportunities specify fixed-term contracts with renewal options and inclusive pricing (delivery and shipping embedded in vendor proposals). Neither opportunity identified set-aside designations for small business, minority business, or veterans business enterprises, though FEMA potential funding in the Seminole County case introduces federal compliance layers such as Clean Air Act and Federal Water Pollution Control Act adherence.
Quick answers
What is UNSPSC 51101661?
UNSPSC 51101661 is Glycobiarsol, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.
Which NIGP codes match UNSPSC 51101661?
UNSPSC 51101661 maps to 1 NIGP code, 26908 Anti-Infective Agents.
On GovTribe
See everything under UNSPSC 51101661
- State & local contract opportunities, awards and contract vehicles under this code
- Contacts who buy under this code
- Ask GovTribe AI about this code